Eventually, it was suggested that IL-1β can induce the inflammatory microenvironment of islets, leading to impaired insulin secretion, decreased cell proliferation and apoptosis of β-cells, ultimately contributing to the development of T2DM (Rhodes, 2005). Here, IL1B is linked to type 2 diabetes mellitus.